01—Abstract
Summary
Summary of the 10-K filed February 25, 2008. Cited figures are marked; the original filing is the authoritative source.
Manhattan Associates, Inc. (Nasdaq: MANH) reported record full-year 2007 results in its Form 10-K filed February 25, 2008.
Total revenue rose 17% to $337.4 milliona from $288.9 million in 2006, with license revenue up 10% to $73.0 million and services revenue up 16% to $226.2 million. Operating income increased 40% to $43.1 million, lifting operating margin to 12.8% from 10.6%, and net income reached $30.8 million, or $1.13 per diluted share, versus $0.69 in 2006. The filing attributes the margin improvement largely to higher license revenue and to the absence of 2006 settlement, acquisition and impairment charges, partly offset by $4.3 million of stock option expense under SFAS 123(R).
Cash flow and balance sheet trends were weaker. Operating cash flow fell to $38.3 millionb from $44.1 million, driven by higher receivables as days sales outstanding rose to 79 days from 73. The company repurchased 3,562,619 shares for $99.9 million during 2007, which reduced cash and investments to $72.8 million from $131.1 million and shareholders' equity to $185.7 million from $237.1 million.
The company carries no debt, and management states that existing cash, cash equivalents and short-term investments will be sufficient for working capital and capital expenditure needs for at least the next twelve months. The filing also highlights risk factors investors should weigh, including quarterly revenue unpredictability, intense competition from ERP vendors such as Oracle and SAP, reliance on a single line of business, and sensitivity to foreign exchange and customer capital budgets. International revenue was $68.7 millionc, about 20% of total revenue, and the company had 2,241 full-time employees at year-end 2007.
02—Key points
Key Highlights
- Total revenue increased 17% to $337.4 million in 2007, with services revenue up 16% to $226.2 million and license revenue up 10% to $73.0 million.
- Operating income rose 40% to $43.1 million, and operating margin expanded to 12.8% from 10.6%.
- Diluted earnings per share increased 64% to $1.13, and net income was $30.8 million.
- Operating cash flow declined to $38.3 million from $44.1 million, as days sales outstanding rose to 79 days from 73.
- The company repurchased 3,562,619 shares for $99.9 million, leaving about $25.0 million of repurchase authority; cash and investments fell to $72.8 million.
- Shareholders' equity decreased to $185.7 million from $237.1 million, and the company reported no debt.
- International revenue was approximately $68.7 million, or about 20% of total revenue, and 2007 included $4.3 million of SFAS 123(R) stock option expense.
03—Questions
Frequently Asked Questions
What drove the improvement in profitability in 2007?
The filing attributes the increase in operating income mainly to higher license revenue and record revenue and operating profit, along with the absence of 2006 settlement, acquisition-related and impairment charges totaling $4.7 million. Stock compensation expense also declined, partly offsetting these gains.
Why did operating cash flow decline in 2007?
Operating cash flow fell to $38.3 million from $44.1 million, principally because of an increase in accounts receivable driven by record revenues, which lifted days sales outstanding to 79 days from 73 days at December 31, 2006.
How did the company use its capital in 2007?
The company used about $99.9 million to repurchase common stock, funded in part by $10.9 million of option exercise proceeds. Net maturities of investments of $84.5 million helped fund these repurchases, reducing total cash, cash equivalents and investments to $72.8 million.
What are the main risks highlighted for investors?
Key risks include difficulty predicting quarterly revenue, intense competition from ERP and supply chain vendors such as Oracle, SAP, JDA and i2, dependence on the supply chain software market as a single line of business, sensitivity to customer capital budgets, foreign currency fluctuations, and the potential for product defects to create liability claims.
04—Continue